期刊文献+

急性冠状动脉综合征高龄患者冠状动脉介入治疗的临床观察 被引量:3

原文传递
导出
摘要 目的:评价经皮冠状动脉介入治疗(PCI)对高龄(年龄≥75岁)急性冠状动脉综合征(ACS)患者的疗效和安全性。方法:入选经PCI治疗的98例高龄ACS患者,评价手术成功率,院内死亡、PCI相关并发症以及随访期间主要心脏不良事件。结果:急诊PCI成功率100%,靶病变介入总成功率95.9%,出血并发症16.7%,院内死亡率1.1%;经(22.9±13.3)个月随访表明主要心脏不良事件为13.4%。结论:PCI治疗ACS高龄患者,是安全有效的,但要注意出血并发症。
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第11期877-878,共2页 Journal of Clinical Cardiology
  • 相关文献

参考文献6

  • 1IGAL T, ABID A, ELI L, et al. Results of percuta- neous coronary interventions in patients≥90 years of age[J]. Catheter Cardiovasc Interv, 2007,70:937 - 943.
  • 2WIEMER M, LANGER C, KOTTMANN T, et al. Outcome in the elderly undergoing percutaneous coro- nary intervention with sirolimus-eluting stents: re- sults from the prospective multicenter German Cypher Stent Registry[J].Am Heart J, 2007,154 : 682 - 687.
  • 3李惟铭,杨新春,王乐丰,葛永贵,王红石,徐立,倪祝华,刘宇,夏昆.75岁以上急性冠状动脉综合征患者应用药物洗脱支架一年随访结果[J].中华老年心脑血管病杂志,2007,9(6):367-369. 被引量:8
  • 4DYNINA O, VAKILI B A, SLATER J N, et al. In- hospital outcomes of contemporary percutaneous coro- nary interventions in the very elderly[J]. Catheter Cardiovasc Interv, 2003,58 : 351 -357.
  • 5沈杰,张奇,张瑞岩,张建盛,胡健,杨震坤,张宪,郑爱芳,沈卫峰.替罗非班在急性冠脉综合征患者中应用的安全性和出血相关因素分析[J].临床内科杂志,2007,24(1):14-17. 被引量:17
  • 6MARENZI G, LAURI G, ASSANELLI E, et al. Con trast-induced nephropathy in patients undergoing primary augiophasty for acute myocardial infaretion[J]. J Am Coll Cardiol, 2004,44 :1780-1785.

二级参考文献10

  • 1ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun NI Jun FANG Yue-hua ZHANG Xian SHEN Wei-feng.One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease[J].Chinese Medical Journal,2006(2):165-168. 被引量:23
  • 2杨新春,王乐丰,李惟铭,葛永贵,王红石,邹阳春,佟子川,徐立,连勇.雷帕霉素药物洗脱支架在老年急性心肌梗死患者急诊经皮冠状动脉介入治疗中的应用[J].中华老年心脑血管病杂志,2006,8(1):9-11. 被引量:6
  • 3沈杰,沈卫峰.替罗非班在急性冠脉综合征介入治疗中的应用[J].国际心血管病杂志,2006,33(3):156-159. 被引量:72
  • 4Francesco S, Pedro A,Chi HL, et al. Sirolimus-eluting stent implantation in ST-segment elevation myocardial infarction[J]. Circulation, 2003,108:1927-1929.
  • 5Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction[J], N Engl J Med, 2006,14; 355: 1093-1104.
  • 6Morice MC,Serruys PW,Sousa JE, et al. A randomized comparison of a sirolimus- eluting stent with a standard stent for coronary revascularization[J]. N Engl J Med, 2002,346: 1773-1780.
  • 7Zahn R, Hamm CW, Schneider S, et al. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry[J]. Am Heart J,2006,152 : 1146-1152.
  • 8Williams DO, Abbott JD, Kevin EK, et al. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the Era of Drug-Eluting Stents Report of the DEScover Registry[J]. Circulation,2006,114:2154-2162.
  • 9Lemos PA, Saia F, Hofma SH, et al. Short and long term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction[J]. J Am Coll Cardiol, 2004,43: 704-708.
  • 10Park CB, Lee CW, Lee BK, et al. Safety and efficacy with drug-eluting stent in ST-segment elevation and non-ST-segment elevation myocardial infarction[J]. Clin Cardiol, 2006,29 : 199-203.

共引文献22

同被引文献31

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部